Expanded access to tenofovir.
D000225:Adenine / Q000031:analogs & derivatives* / Q000600:supply & distribution*; D002170:Canada; D005060:Europe; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000600:supply & distribution*; D018894:Reverse Transcriptase Inhibitors / Q000600:supply & distribution*; D000068698:Tenofovir; D014481:United States
D063065:Organophosphonates; D009943:Organophosphorus Compounds; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine